Refreshing results…
ESR1 F404 mutations and acquired resistance to fulvestrant in ESR1 mutant breast cancer
UploadHER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway
Download from doi.orgINK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors
UploadTERT promoter hotspot mutations and gene amplification in metaplastic breast cancer
Download from www.nature.comAKT1 E17K inhibits cancer cell migration by abrogating β-catenin signaling
Download from aacrjournals.orgThe genomic landscape of metastatic histologic special types of invasive breast cancer
Download from www.nature.comMutant SF3B1 promotes AKT and NF-kB driven mammary tumorigenesis
Download from doi.orgDouble PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
UploadReversible histone glycation is associated with disease-related changes in chromatin architecture
Download from www.nature.comLoss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway
UploadNeratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)
UploadMissing publications? Search for publications with a matching author name.